597543-25-4

Basic information

• Product Name: 2-Pyrrolidinemethanol, 1-[2,4-dimethyl-3-[[(2-methyl-8-quinolinyl)oxy]methyl]phenyl]-, (2R)-
• CAS NO: 597543-25-4
• Molecular Formula: C24H28N2O2
• Molecular Weight: 376.499
• Mol File: 597543-25-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-Pyrrolidinemethanol, 1-[2,4-dimethyl-3-[[(2-methyl-8-quinolinyl)oxy]methyl]phenyl]-, (2R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyrrolidinemethanol, 1-[2,4-dimethyl-3-[[(2-methyl-8-quinolinyl)oxy]methyl]phenyl]-, (2R)-(597543-25-4)
• EPA Substance Registry System: 2-Pyrrolidinemethanol, 1-[2,4-dimethyl-3-[[(2-methyl-8-quinolinyl)oxy]methyl]phenyl]-, (2R)-(597543-25-4)

Safety Data

• Hazardous Substances Data: 597543-25-4(Hazardous Substances Data)

Upstream product

• 617721-55-8 1-[2,4-dimethyl-3-(2-methyl-quinolin-8-yloxymethyl)-phenyl]-pyrrolidine-2-(R)-carboxylic acid tert-butyl ester 
• 597543-24-3 1-[2,4-dimethyl-3-(2-methyl-quinolin-8-yloxymethyl)-phenyl]-pyrrolidine-2-(R)-carboxylic acid 
• 597543-18-5 8-(3-bromo-2,6-dimethyl-benzyloxy)-2-methyl-quinoline 
• 86246-72-2 (3-bromo-2,6-dimethylphenyl)methanol 
• 632-46-2 2,6-dimethylbenzoic acid 
• 826-81-3 2-methyl-8-quinolinol 

Downstream Products

• 617721-56-9 C-{1-[2,4-dimethyl-3-(2-methyl-quinolin-8-yloxymethyl)-phenyl]-pyrrolidin-2-yl}-methylamine 

Relevant articles and documents

Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators

This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.

NOVEL HETEROARYL ALKYLAMIDE DERIVATIVES USEFUL AS BRADYKININ RECEPTOR MODULATORS

This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.